Globeflex Capital L P Acquires New Holdings in Encompass Health Corporation $EHC

Posted by Geri Gentry on Aug 25th, 2026

Globeflex Capital L P bought a new position in Encompass Health Corporation (NYSE:EHC – Free Report) in the second quarter, according to the company in its most recent disclosure with the SEC. The fund bought 11,065 shares of the company’s stock, valued at approximately $1,118,000.

A number of other hedge funds have also added to or reduced their stakes in the stock. Persistent Asset Partners Ltd bought a new stake in shares of Encompass Health in the second quarter worth $36,000. Keating Financial Advisory Services Inc. purchased a new stake in Encompass Health during the second quarter valued at $39,000. Assetmark Inc. lifted its holdings in Encompass Health by 89.6% in the first quarter. Assetmark Inc. now owns 455 shares of the company’s stock valued at $44,000 after acquiring an additional 215 shares during the period. Caitong International Asset Management Co. Ltd boosted its position in Encompass Health by 36,200.0% in the third quarter. Caitong International Asset Management Co. Ltd now owns 363 shares of the company’s stock worth $46,000 after purchasing an additional 362 shares during the last quarter. Finally, Aster Capital Management DIFC Ltd bought a new stake in shares of Encompass Health during the 4th quarter valued at about $55,000. 97.25% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Encompass Health news, EVP John Patrick Darby sold 8,906 shares of the stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $125.95, for a total transaction of $1,121,710.70. Following the completion of the transaction, the executive vice president owned 75,041 shares of the company’s stock, valued at $9,451,413.95. This represents a 10.61% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Mark J. Tarr sold 173,148 shares of Encompass Health stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $125.47, for a total value of $21,724,879.56. Following the completion of the sale, the chief executive officer directly owned 267,814 shares in the company, valued at $33,602,622.58. This trade represents a 39.27% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Company insiders own 1.80% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have recently weighed in on EHC. Leerink Partners set a $152.00 price objective on shares of Encompass Health in a research note on Friday, May 22nd. Wall Street Zen upgraded shares of Encompass Health from a “hold” rating to a “buy” rating in a research report on Sunday, August 16th. TD Cowen lifted their price target on shares of Encompass Health from $125.00 to $140.00 and gave the stock a “buy” rating in a research note on Monday, August 10th. UBS Group boosted their price objective on shares of Encompass Health from $150.00 to $155.00 and gave the company a “buy” rating in a research report on Friday, August 7th. Finally, Truist Financial raised their target price on Encompass Health from $140.00 to $150.00 and gave the stock a “buy” rating in a report on Friday, August 7th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Encompass Health has an average rating of “Buy” and a consensus target price of $148.71.

Read Our Latest Research Report on EHC

Encompass Health Stock Performance

Shares of NYSE EHC opened at $120.94 on Tuesday. The stock has a market cap of $11.93 billion, a PE ratio of 19.70, a price-to-earnings-growth ratio of 2.43 and a beta of 0.72. Encompass Health Corporation has a 1 year low of $92.77 and a 1 year high of $127.99. The firm has a fifty day moving average price of $111.44 and a 200-day moving average price of $106.66. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.19 and a quick ratio of 1.19.

Encompass Health (NYSE:EHC – Get Free Report) last issued its earnings results on Wednesday, August 5th. The company reported $1.55 earnings per share for the quarter, topping the consensus estimate of $1.48 by $0.07. The company had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.57 billion. Encompass Health had a net margin of 10.01% and a return on equity of 18.08%. Encompass Health’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.40 EPS. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. Equities analysts anticipate that Encompass Health Corporation will post 6.09 earnings per share for the current fiscal year.

Encompass Health Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Thursday, October 1st will be paid a dividend of $0.21 per share. This is a boost from Encompass Health’s previous quarterly dividend of $0.19. The ex-dividend date of this dividend is Thursday, October 1st. This represents a $0.84 annualized dividend and a yield of 0.7%. Encompass Health’s dividend payout ratio is 12.38%.

Encompass Health Company Profile

(Free Report)

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.